Fluoroazomycin arabinoside F-18
- Generic Name
- Fluoroazomycin arabinoside F-18
- Drug Type
- Small Molecule
- Chemical Formula
- C8H10FN3O5
- CAS Number
- 864084-85-5
- Unique Ingredient Identifier
- UG7I3Y42PV
Overview
Fluoroazomycin arabinoside F-18 is under investigation in clinical trial NCT03257150 (A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer).
Background
Fluoroazomycin arabinoside F-18 is under investigation in clinical trial NCT03257150 (A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath